PPARA and fatty liver disease: Importantly, the present study indicates a possible mechanism whereby the combination of GCN2 deficiency and exercise may suppress the initiation of HFD-induced hepatic steatosis more effectively by activation of the AMPK/SIRT1/PPARα pathway in the liver.